Otsuka F, Shima A, Ishibashi Y
Department of Dermatology, Faculty of Medicine, University of Tokyo, Japan.
Cancer. 1989 Mar 1;63(5):891-6. doi: 10.1002/1097-0142(19890301)63:5<891::aid-cncr2820630516>3.0.co;2-g.
Clinical evidence has accumulated of malignant epithelial tumors developing on the lesions of porokeratosis. To determine the cytologic basis for the malignant change of porokeratosis, the nuclear DNA content of epidermal cells from porokeratotic lesions was measured using microfluorometry. A total of 42% of 33 porokeratotic skin lesions in eight of the 16 patients showed DNA polyploidization in the epidermis. Most of the porokeratotic skin lesions, with or without DNA polyploidization, increase cell proportions in the S and G2/M phase range. DNA indices of cells from these porokeratotic lesions distributed widely from the level of normal control epidermis to that of malignant epidermal conditions. These findings suggest that porokeratosis is undergoing the neoplastic process, and is a precursor of malignant tumors.
临床证据已积累表明,在汗孔角化症病变上会发生恶性上皮肿瘤。为确定汗孔角化症恶变的细胞学基础,使用显微荧光测定法测量了汗孔角化症病变表皮细胞的核DNA含量。16例患者中有8例的33处汗孔角化症皮肤病变,总计42%在表皮显示出DNA多倍体化。大多数汗孔角化症皮肤病变,无论有无DNA多倍体化,S期和G2/M期范围的细胞比例均增加。这些汗孔角化症病变细胞的DNA指数从正常对照表皮水平到恶性表皮状况水平广泛分布。这些发现表明,汗孔角化症正经历肿瘤形成过程,是恶性肿瘤的前驱病变。